{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:30:51Z","timestamp":1787725851452,"version":"build-2784847793"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polo-like kinase 1 (PLK1) and forkhead box M1 (FOXM1) have been widely studied in various cancers; however, their expression characteristics in endometrial cancer (EC) and their potential association with tumor microenvironment remodeling remain insufficiently characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study integrated The Cancer Genome Atlas uterine corpus endometrial carcinoma cohort, Gene Expression Omnibus, pan-cancer transcriptomic data, Human Protein Atlas\/Clinical Proteomic Tumor Analysis Consortium, and local immunohistochemistry data to evaluate PLK1 expression and clinicopathological relevance across transcriptomic, proteomic, and histopathological data. Differential expression, survival, gene-set enrichment, transcription-factor enrichment, and immune-infiltration analyses characterized PLK1-associated features.\n                      <jats:italic>In vitro<\/jats:italic>\n                      experiments combined EC cell lines AN3CA and HEC-1A with co-immunoprecipitation, Western blotting, Transwell assays, and a THP-1 conditioned-medium model. Drug-response prediction and structure-based analysis prioritized candidate therapeutic hypotheses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PLK1 was consistently upregulated at both mRNA and protein levels in EC and was associated with higher tumor grade and International Federation of Gynecology and Obstetrics (FIGO) stage. In survival analysis, higher PLK1 expression was associated with poorer overall survival in univariable models but not after adjustment for age, tumor grade, and FIGO stage. Functional enrichment analysis showed that PLK1-associated genes were mainly involved in cell-cycle and mitotic processes. FOXM1 was identified as a potential candidate component of the PLK1-associated transcriptional program and was positively correlated with PLK1 expression and cell-cycle-related features.\n                      <jats:italic>In vitro<\/jats:italic>\n                      experiments supported an interaction between PLK1 and FOXM1 and suggested that FOXM1 Thr600 phosphorylation-related alterations were associated with migration and invasion phenotypes. Furthermore, the PLK1\/FOXM1-associated tumor-cell state was linked to macrophage-related immune features and changes in the M2-like marker profile of THP-1-derived macrophage-like cells. Drug response analyses suggested differential predicted sensitivity patterns in PLK1-high tumors, providing candidate therapeutic hypotheses for further validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The PLK1\/FOXM1-associated tumor-cell state may represent a distinct molecular feature associated with proliferative activity, invasive phenotypes, and macrophage-related immune features in EC. This study provides preliminary evidence supporting the biological relevance of this molecular feature and highlights potential therapeutic directions for future investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1931435","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:04:28Z","timestamp":1787724268000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["PLK1\/FOXM1-associated tumor-cell state and macrophage-related immune features in endometrial cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Longwei","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gynecology, Dalian Women and Children\u2019s Medical Center (Group), The Affiliated Women and Children\u2019s Hospital of Dalian University of Technology, Liaoning Provincial Key Laboratory for Early Diagnosis and Biotherapy of Women\u2019s and Children\u2019s Malignant Tumors","place":["Dalian, China"]},{"name":"Graduate School of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Dalian Women and Children\u2019s Medical Center (Group), The Affiliated Women and Children\u2019s Hospital of Dalian University of Technology, Liaoning Provincial Key Laboratory for Early Diagnosis and Biotherapy of Women\u2019s and Children\u2019s Malignant Tumors","place":["Dalian, China"]},{"name":"Graduate School of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dalian Women and Children\u2019s Medical Center (Group), The Affiliated Women and Children\u2019s Hospital of Dalian University of Technology, Liaoning Provincial Key Laboratory for Early Diagnosis and Biotherapy of Women\u2019s and Children\u2019s Malignant Tumors","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dalian Women and Children\u2019s Medical Center (Group), The Affiliated Women and Children\u2019s Hospital of Dalian University of Technology, Liaoning Provincial Key Laboratory for Early Diagnosis and Biotherapy of Women\u2019s and Children\u2019s Malignant Tumors","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dalian Women and Children\u2019s Medical Center (Group), The Affiliated Women and Children\u2019s Hospital of Dalian University of Technology, Liaoning Provincial Key Laboratory for Early Diagnosis and Biotherapy of Women\u2019s and Children\u2019s Malignant Tumors","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Dalian Women and Children\u2019s Medical Center (Group), The Affiliated Women and Children\u2019s Hospital of Dalian University of Technology, Liaoning Provincial Key Laboratory for Early Diagnosis and Biotherapy of Women\u2019s and Children\u2019s Malignant Tumors","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Dalian Women and Children\u2019s Medical Center (Group), The Affiliated Women and Children\u2019s Hospital of Dalian University of Technology, Liaoning Provincial Key Laboratory for Early Diagnosis and Biotherapy of Women\u2019s and Children\u2019s Malignant Tumors","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6748a1","article-title":"Uterine cancer incidence and mortality - United States, 1999-2016","volume":"67","author":"Henley","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174176","article-title":"Recurrent endometrial cancer: which is the best treatment","volume":"14","author":"Restaino","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429343090250121052955","article-title":"Two GnRH-mitoxantrone conjugates, Con-3 and Con-7, target endometrial cancer cells","volume":"17","author":"Markatos","year":"2024","journal-title":"Curr Mol Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2174\/0109298665400400251003013958","article-title":"Role of TPD52 in endometrial cancer: impact on EMT and the PI3K\/AKT and ERK\/MAPK signaling","volume":"32","author":"Miao","year":"2025","journal-title":"Protein Pept Lett"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429315431240712100124","article-title":"The role of local angiotensin II\/angiotensin type 1 receptor in endometriosis: a potential target for new treatment approaches","volume":"17","author":"Moazen","year":"2024","journal-title":"Curr Mol Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.903016","article-title":"Present and future perspective on PLK1 inhibition in cancer treatment","volume":"12","author":"Chiappa","year":"2022","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.4177","article-title":"Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients","volume":"15","author":"He","year":"2009","journal-title":"World J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.12659\/msm.882900","article-title":"Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells","volume":"18","author":"Han","year":"2012","journal-title":"Med Sci Monit"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-019-0247-4","article-title":"Therapeutic potential of PLK1 inhibition in triple-negative breast cancer","volume":"99","author":"Ueda","year":"2019","journal-title":"Lab Invest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1545038","article-title":"Onvansertib exhibits anti-proliferative and anti-invasive effects in endometrial cancer models","volume":"16","author":"Sinha","year":"2025","journal-title":"Front Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1767","article-title":"Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression","volume":"10","author":"Fu","year":"2008","journal-title":"Nat Cell Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091344","article-title":"The role of Polo-like kinase 1 in regulating the Forkhead box family transcription factors","volume":"12","author":"Moore","year":"2023","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/B978-0-12-407190-2.00016-2","article-title":"FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy","volume":"119","author":"Wierstra","year":"2013","journal-title":"Adv Cancer Res"},{"key":"B15","article-title":"FOXM1 as a prognostic biomarker promotes endometrial cancer progression via transactivation of SLC27A2 expression","volume":"11","author":"Feng","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1213347","article-title":"The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer","volume":"13","author":"Sun","year":"2023","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1186\/s12967-025-06235-6","article-title":"Metabolic interplay between endometrial cancer and tumor-associated macrophages: lactate-induced M2 polarization enhances tumor progression","volume":"23","author":"Liu","year":"2025","journal-title":"J Transl Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13046-023-02872-1","article-title":"Invasive FoxM1 phosphorylated by PLK1 induces monocyte-derived M2-like tumor-associated macrophage polarization to facilitate immune escape and metastasis in LUAD","volume":"42","author":"Xu","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","year":"2013","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets-update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16015","DOI":"10.1038\/npjsba.2016.15","article-title":"L1000CDS2: LINCS L1000 characteristic direction signatures search engine","volume":"2","author":"Duan","year":"2016","journal-title":"NPJ Syst Biol Appl"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief Bioinform"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein-ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-023-00705-z","article-title":"PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions","volume":"31","author":"Pan","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1702273","article-title":"Clinical relevance of PLK1 in epithelial ovarian cancer","volume":"16","author":"Shen","year":"2025","journal-title":"Front Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2006.12.037","article-title":"BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo","volume":"17","author":"Steegmaier","year":"2007","journal-title":"Curr Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0945","article-title":"Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis","volume":"69","author":"Gilmartin","year":"2009","journal-title":"Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2024.12.003","article-title":"Palbociclib plus letrozole in estrogen receptor-positive advanced\/recurrent endometrial cancer: double-blind placebo-controlled randomized phase II ENGOT-EN3\/PALEO trial","volume":"192","author":"Mirza","year":"2025","journal-title":"Gynecol Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.3401","article-title":"Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma","volume":"33","author":"Slomovitz","year":"2015","journal-title":"J Clin Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.626836","article-title":"FOXM1 and cancer: faulty cellular signaling derails homeostasis","volume":"10","author":"Kalathil","year":"2021","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2957","article-title":"FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells","volume":"6","author":"Chiu","year":"2015","journal-title":"Oncotarget"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct Target Ther"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1931435\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:04:29Z","timestamp":1787724269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1931435\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":41,"alternative-id":["10.3389\/fonc.2026.1931435"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1931435","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1931435"}}